戻る Agenda
Session 26: FDA Warning Letters
Session Chair(s)
Jill W. Buckley, PHARMD
Adjunct Assistant Professor
Rutgers, the State University of New Jersey, United States
A review of recent findings from several FDA Post-Marketing Adverse Drug Experience inspections will be discussed using Warning Letters to identify observations.